White Paper

Biomarker Selection and Measurement in Neurodegenerative Clinical Trials

Read more

Neurodegenerative diseases like Alzheimer’s, Parkinson’s, Huntington’s, ALS, and Multiple Sclerosis are some of the most complex and challenging conditions in medical research. These disorders, driven by progressive neuronal degeneration, cause debilitating symptoms that vary widely among patients. Download our white paper to discover the critical role protein biomarkers play in early diagnosis, tracking disease progression, and evaluating treatment efficacy in clinical trials.

Authors:

Chief Development Officer
Vice President, Scientific Solutions, Neuroscience

Want to learn more about Worldwide Clinical Trials?